Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Phase 3 Data

Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The...

from NDTV News - Special https://ift.tt/2TyByf1